Lilly Announces New Leadership
Eli Lilly and Company announced Josh Bilenker (pictured), Nisha Nanda (pictured) and Jacob Van Naarden will jointly lead the company’s new organization, Loxo Oncology at Lilly. All three serve in management at Loxo, which Lilly acquired in early 2019. The company also announced that David Hyman will join the leadership team as chief medical officer of the new organization, […]... Read More
